Cost-Effective Lapatinib Ditosylate Monohydrate
Advanced Pharmaceutical Intermediate for Targeted Breast Cancer Therapy
Get a Quote & SampleProduct Core Value
Lapatinib Ditosylate Monohydrate
This product is a highly cost-effective pharmaceutical intermediate, crucial for the development of advanced treatments for HER2-positive breast cancer. It acts as a receptor tyrosine kinase inhibitor, specifically targeting the ErbB-1 and ErbB-2 subtypes.
- As a key player in targeted cancer therapy, this Lapatinib intermediate is vital for developing drugs against HER2-positive advanced breast cancer.
- The product's mechanism of action as a tyrosine kinase inhibitor makes it instrumental in blocking cancer cell growth signals.
- We offer this pharmaceutical intermediate for breast cancer treatment with a focus on cost-effectiveness, aiding efficient drug development.
- The availability of this Lapatinib intermediate for oral administration, often in combination with other agents, supports patient compliance and treatment efficacy.
Key Advantages Offered
Cost-Effectiveness
Leverage our cost-effective Lapatinib intermediate for breast cancer treatment to optimize your pharmaceutical R&D budgets.
Targeted Efficacy
Utilize this advanced pharmaceutical intermediate for breast cancer treatment to achieve targeted efficacy against HER2-positive tumors.
Reliable Supply Chain
Secure a dependable supply of this Lapatinib intermediate for breast cancer treatment directly from the factory, ensuring production continuity.
Key Applications
Oncology Drug Development
This Lapatinib intermediate is essential for the pharmaceutical synthesis of novel cancer therapies, contributing to advancements in oncology drug development.
Advanced Breast Cancer Treatment
The product plays a critical role in developing treatments for HER2-positive advanced breast cancer, offering new hope to patients.
Pharmaceutical Intermediate Sourcing
Companies can reliably source this crucial intermediate for breast cancer treatment, ensuring the availability of essential raw materials.
Targeted Therapy Solutions
As a key tyrosine kinase inhibitor intermediate, it facilitates the creation of targeted therapy solutions for specific cancer subtypes.